These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 6236345

  • 1. [Selection of donors for bone marrow transplantation].
    Kastelan A, Kastelan M, Labar B.
    Lijec Vjesn; 1984 Jun; 106(6):241-5. PubMed ID: 6236345
    [No Abstract] [Full Text] [Related]

  • 2. Future directions in selection of donors for bone marrow transplantation: role of oligonucleotide genotyping.
    Baxter-Lowe LA, Eckels DD, Ash R, Casper J, Hunter JB, Gorksi J.
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1699-700. PubMed ID: 1824902
    [No Abstract] [Full Text] [Related]

  • 3. Bone marrow transplantation with unrelated donors: HLA class II oligonucleotide typing as predictive of mixed lymphocyte culture reactivity.
    Tiercy JM, Roosnek E, Mach B, Jeannet M.
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1243-5. PubMed ID: 8442103
    [No Abstract] [Full Text] [Related]

  • 4. Searches for matched and closely matched marrow donors undertaken in a paediatric unit.
    Vowels M, Honeyman M, Ziegler J, White L, Doran T, Lane J, Lam-Po-Tang R.
    Transplant Proc; 1990 Oct; 22(5):2171. PubMed ID: 2145674
    [No Abstract] [Full Text] [Related]

  • 5. [Determination of histocompatibility using cell-mediated lympholysis].
    Potmĕsilová I, Soucek J, Novák JT.
    Vnitr Lek; 1980 Nov; 26(11):1072-8. PubMed ID: 6455007
    [No Abstract] [Full Text] [Related]

  • 6. Mixed leukocyte culture reactivity, HLA-DP typing and GVHD.
    Moreau P, Milpied N, Cesbron A, Mahe B, Bignon JD, Harousseau JL.
    Bone Marrow Transplant; 1993 Jan; 11(1):85-6. PubMed ID: 8431717
    [No Abstract] [Full Text] [Related]

  • 7. Evaluation of HLA-DPB incompatibility by PCR-SSCP in the choice of a bone marrow donor.
    Pietravalle F, Tkaczuk J, Thomsen M, Cambon-Thomsen A, Ohayon E, Abbal M.
    Transplant Proc; 1994 Feb; 26(1):238. PubMed ID: 8108956
    [No Abstract] [Full Text] [Related]

  • 8. Role of the mixed lymphocyte culture reaction in predicting acute graft-versus-host disease after marrow transplants from haploidentical and unrelated donors.
    Mickelson EM, Anasetti C, Yoon Choo S, Longton GM, Petersdorf EW, Martin PJ, Hansen JA.
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1239-40. PubMed ID: 8442101
    [No Abstract] [Full Text] [Related]

  • 9. [Selection of bone marrow donors for allogeneic transplantation. General principles].
    Wiktor-Jedrzejczak W.
    Acta Haematol Pol; 1987 Feb; 18(3-4):199-202. PubMed ID: 3330396
    [No Abstract] [Full Text] [Related]

  • 10. [Donor selection for allogenic bone marrow transplantation from 1991 to 1995. (The Prague Center for Bone Marrow Transplantation)].
    Korínková P, Matĕjková E, Vítek A.
    Cas Lek Cesk; 1996 Jun 12; 135(12):389-92. PubMed ID: 8706078
    [Abstract] [Full Text] [Related]

  • 11. Interferon-gamma-based mixed lymphocyte culture as a selection tool for allogeneic bone marrow donors other than identical siblings.
    van der Meer A, Wissink WM, Schattenberg AV, Joosten I.
    Br J Haematol; 1999 May 12; 105(2):340-8. PubMed ID: 10233402
    [Abstract] [Full Text] [Related]

  • 12. [Typization and selection of marrow donors through the determination of HLA antigen and MLC reaction].
    Kastelan A.
    Lijec Vjesn; 1978 Jun 12; 100(6):385-6. PubMed ID: 151770
    [No Abstract] [Full Text] [Related]

  • 13. Unrelated donor matching for bone marrow transplantation.
    Chopek M, Alosco S, Salazar M, Yunis EJ.
    Transplant Proc; 1993 Feb 12; 25(1 Pt 2):1255-8. PubMed ID: 8442106
    [Abstract] [Full Text] [Related]

  • 14. Significance of MLC for BMT with serological HLA-identical related and unrelated donors.
    Bonfichi M, Bernasconi P, Brera C, Boni M, Caldera C, Campagnoli C, Alessandrino EP, Bernasconi C.
    Bone Marrow Transplant; 1993 Feb 12; 11 Suppl 1():28-30. PubMed ID: 8448540
    [No Abstract] [Full Text] [Related]

  • 15. [Bone marrow transplantation from donors other than HLA matched siblings for hematological malignancies. Nagoya Bone Marrow Transplantation Group and Tokai Marrow Donor Bank].
    Matsumoto K, Horibe K, Akatsuka Y, Minami S, Matsuyama T, Hirabayashi N, Tanimoto M, Yamada H, Sobue R, Morishima Y.
    Rinsho Ketsueki; 1994 Aug 12; 35(8):729-37. PubMed ID: 7933558
    [Abstract] [Full Text] [Related]

  • 16. Bone marrow transplants using unrelated donors.
    Madrigal JA.
    Bone Marrow Transplant; 1998 Apr 12; 21 Suppl 2():S2-4. PubMed ID: 9630314
    [Abstract] [Full Text] [Related]

  • 17. [Significance and features of MLC reaction in histocompatibility determination of donor and recipient in allogenic bone marrow transplantation to patients with hematological malignancies].
    Shpakova AP, Bulycheva TI, Liubimova LS, Mendeleeva LP.
    Ter Arkh; 2000 Apr 12; 72(11):62-7. PubMed ID: 11229316
    [Abstract] [Full Text] [Related]

  • 18. [Tests for donors of blood and bone marrow].
    Taniwaki K, Itoh M, Misawa M, Hara H.
    Rinsho Byori; 1995 Jul 12; Suppl 99():102-10. PubMed ID: 7474414
    [No Abstract] [Full Text] [Related]

  • 19. [Bone marrow donors and the scientific and organizational problems of creating a marrow bank].
    Iarustovskaia LE, Bogoiavlenskaia MP.
    Probl Gematol Pereliv Krovi; 1981 Feb 12; 26(2):53-5. PubMed ID: 7015312
    [No Abstract] [Full Text] [Related]

  • 20. Past and future of providing matched, unrelated donors for marrow transplantation.
    Roeckel IE, Baker J.
    Ann Clin Lab Sci; 1997 Feb 12; 27(5):346-50. PubMed ID: 9303173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.